Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 10 of 10 for “"UGT1A6"”.
-
Functional validation of UGT1A6 in anthracycline-induced cardiotoxicity
… the goal of functionally exploring the role of UGT1A6 in relation to a patient’s risk of the adverse drug reaction (ADR) known as anthracycline-induced cardiotoxicity. More specifically, the variant in UGT1A6 known as rs17863783 has been previously shown, along with other genetic and clinical …
-
Structure-function relationship of uridine diphosphate glucuronosyltransferases (UGTs)
… vivo. METHODS N-glycosylation variants of human UGT1A6 were established to study the influence of N-glycosylation on their expression, activity, cellular function and localization. HEK293 expressed UGT1A6-(His)6 and Sf9-insect expressed soluble UGT1A6 were purified and their activity and latency …
-
Ο μεταβολισμός του βαλπροϊκού οξέος: o ρόλος των πολυμορφισμών των γονιδίων UGT1A6 και UGT2B7 στην ηπατική γλυκουρονίδωση του βαλπροϊκού οξέος σε ανήλικους και ενήλικους ασθενείς
Aim: To clarify the impact of UGT1A6 and UGT2B7 gene polymorphisms on the metabolism of valproic acid.Method/Patients: Adult patients (age ≥ 16 years) hospitalized in the Neurology Department as well as adult patients of the Epilepsy Outpatient Clinic and children patients of the Pediatric …
-
An investigation of the role of pharmacogenetics in the development and prevention of anthracycline-induced cardiotoxicity
… of ACT. The gene variants RARG-rs2229774, UGT1A6-rs17863783, and SLC28A3-rs7853758 have the strongest evidence for association with ACT in anthracycline-treated patients. First, this thesis aimed to understand the scope of genetics, focusing on the proposed roles of genes RARG, UGT1A6, and …
-
SYNTHESIS AND CHARACTERIZATION OF RESVERATROL AND ITS CONJUGATED METABOLITES AND CONTRIBUTION OF METABOLISM TO ITS DECREASED BIOVAILABILITY
… polymorphisms in the major enzymes (UGT1A1 and UGT1A6) and rates of glucuronidation of trans and cis-resveratrol. We set out to correlate functional genetic variations in these UGTs with their catalytic rates and a positive association was made for cis-resveratrol and UGT1A6 where the UGT1A6 …
-
The development of dose-adjusted pharmacogenetic prediction models in pediatric oncology
… been published outlining the roles of SLC28A3, UGT1A6, and RARG in anthracycline-induced cardiotoxicity, and TPMT in cisplatin-induced ototoxicity. While both anthracycline- and cisplatin-induced toxicities are dose-dependent reactions, no studies have explored the dose-gene relationship in the …
-
ANALYSIS OF DIFFERENTIAL GENE EXPRESSION AND ALTERNATIVE SPLICING IN THE LIVER AND GASTROINTESTINAL TRACT IN THE LACTATING RAT
… We also detected differential expression of Ugt1a6 in the liver based on usage of an alternative first exon, which is consistent with altered protein levels observed previously. Differential splicing also appears to occur in Ace2 in the ileum, which could have consequences on the …
-
Colorectal cancer and detoxification enzymes, with emphasis on enzyme modulation and genetic polymorphisms.
… that polymorphisms in the detoxification enzymes UGT1A6, UGT1A7 and NQO1 were found significantly more often in patients with CRC as compared to healthy controls, indicating that the presence of these variant genotypes may contribute to development of CRC. Finally, we showed by measuring oxygen …
-
Investigating complex phenotypes: haplotype association mapping benzene pharmacokinetics in isogenic mouse strains
… primary benzene-metabolizing enzymes CYP2E1 and UGT1A6 showed very little strain-dependent variation. Strain dependent differences in mRNA levels of NQO1 and MPO were small but statistically significant, as were those for GAPDH and β2-microglobulin. These data demonstrated that polymorphisms with …
-
Novel methods for the detection, risk stratification and management of early colorectal cancer and pre-malignant lesions
… APC, EGFR, COX1/2, IL23R, DRD2, CYP2C9/24A1/7A1, UGT1A6, ODC, ALOX12/15, PGDH, SRC, IGSF5, KCNS3, EPHB1/ KY, FAM188b, 3p24.1, 9q33.2, 13q33.2) were found to predict metachronous adenoma / advanced adenoma risk, while the expression levels of 6 proteins correlated with metachronous adenoma (p53, …